Johnson & Johnson Recalls Duragesic Pain Patches

Johnson & Johnson has recalled more than 53,000 Duragesic pain relief skin patches, according to a Wall Street Journal report.

The company said that at least one patch was found to have small crystals of the potent active ingredient.

Related Articles on Pain Management:

Convergence Pharmaceuticals Neuropatic Pain Drug Completes Phase I Trials
Trial for Boston Scientific's Spinal Cord Stimulation Device Shows Promising Results
Oregon House Co-Speaker Visits Middle Fork Surgery Center for Pain Management Policy Discussion

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast